- Home
- NRC vs VRCA Comparison
NRC vs VRCA Comparison
Compare NRC & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- VRCA
- Stock Information
- Founded
- NRC 1981
- VRCA 2013
- Country
- NRC United States
- VRCA United States
- Employees
- NRC N/A
- VRCA N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- NRC Health Care
- VRCA Health Care
- Exchange
- NRC Nasdaq
- VRCA Nasdaq
- Market Cap
- NRC 426.3M
- VRCA 363.1M
- IPO Year
- NRC N/A
- VRCA 2018
- Fundamental
- Price
- NRC $17.17
- VRCA $0.69
- Analyst Decision
- NRC
- VRCA Hold
- Analyst Count
- NRC 0
- VRCA 5
- Target Price
- NRC N/A
- VRCA $6.00
- AVG Volume (30 Days)
- NRC 114.1K
- VRCA 749.9K
- Earning Date
- NRC 02-11-2025
- VRCA 11-04-2024
- Dividend Yield
- NRC 2.80%
- VRCA N/A
- EPS Growth
- NRC N/A
- VRCA N/A
- EPS
- NRC 1.12
- VRCA N/A
- Revenue
- NRC $144,155,000.00
- VRCA $9,210,000.00
- Revenue This Year
- NRC N/A
- VRCA $54.16
- Revenue Next Year
- NRC N/A
- VRCA $99.78
- P/E Ratio
- NRC $15.29
- VRCA N/A
- Revenue Growth
- NRC N/A
- VRCA 187.45
- 52 Week Low
- NRC $16.74
- VRCA $0.61
- 52 Week High
- NRC $42.18
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- NRC 35.82
- VRCA 33.00
- Support Level
- NRC $16.74
- VRCA $0.61
- Resistance Level
- NRC $18.31
- VRCA $1.32
- Average True Range (ATR)
- NRC 0.80
- VRCA 0.11
- MACD
- NRC -0.22
- VRCA -0.02
- Stochastic Oscillator
- NRC 13.46
- VRCA 12.08
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.